Abstract: Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Abstract: A radiation imaging system comprises a movable radiation source adapted to be disposed in a plurality of respective radiation source positions; a radiation detector and a collimator assembly configured to displace a collimator in a plurality of respective collimator positions, each of the collimator positions being coordinated with at least one of the radiation source positions such that a radiation beam emanating from the radiation source is collimated to limit radiation incident on the detector to a predetermined exposure area. Another radiation imaging system comprises a movable radiation source; a radiation detector; and a collimator comprising an adjustable geometry aperture assembly configured such that an adjustment of the aperture geometry is synchronized with the movement of the radiation source and coordinated with the radiation source position so as to limit the incident radiation to a predetermined exposure area at the detector.

Abstract: Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Abstract: Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Abstract: Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Abstract: Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Abstract: The present invention relates to a food or drink container integrated with a noisemaking device. According to a preferred embodiment, the device comprises an enclosure containing at least one pellet which makes noise when shaken as the fan cheers for a sports team or at a concert. The enclosure is a preformed shape with sufficient dimensions to be affixed to or formed with a food or beverage container sold at the concessions stand at stadiums and arenas. A fan may then consume food and drink and utilize the noisemaker concurrently therewith. The fan may then detach the noisemaker and throw away the food or beverage container thereby retaining the noisemaker as a souvenir and for future use at other events.

Abstract: Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Abstract: Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Abstract: Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Abstract: Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Abstract: A radiation imaging system comprises a movable radiation source adapted to be disposed in a plurality of respective radiation source positions; a radiation detector and a collimator assembly configured to displace a collimator in a plurality of respective collimator positions, each of the collimator positions being coordinated with at least one of the radiation source positions such that a radiation beam emanating from the radiation source is collimated to limit radiation incident on the detector to a predetermined exposure area. Another radiation imaging system comprises a movable radiation source; a radiation detector; and a collimator comprising an adjustable geometry aperture assembly configured such that an adjustment of the aperture geometry is synchronized with the movement of the radiation source and coordinated with the radiation source position so as to limit the incident radiation to a predetermined exposure area at the detector.

Abstract: A radiation imaging system comprises a movable radiation source adapted to be disposed in a plurality of respective radiation source positions; a radiation detector and a collimator assembly configured to displace a collimator in a plurality of respective collimator positions, each of the collimator positions being coordinated with at least one of the radiation source positions such that a radiation beam emanating from the radiation source is collimated to limit radiation incident on the detector to a predetermined exposure area. Another radiation imaging system comprises a movable radiation source; a radiation detector; and a collimator comprising an adjustable geometry aperture assembly configured such that an adjustment of the aperture geometry is synchronized with the movement of the radiation source and coordinated with the radiation source position so as to limit the incident radiation to a predetermined exposure area at the detector.

Abstract: Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Abstract: The present invention is concerned with pharmaceutical formulations comprising a combination of salmeterol and ipratropium and the use of such formulations in medicine, particularly in the prophylaxis and treatment of respiratory diseases.

Abstract: 4-Substituted-3-substituted-amino-cyclobut-3-ene-1,2-diones having the Formula (I): 1

Abstract: Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Abstract: Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Abstract: Compounds represented by formula (Ia) are disclosed by the invention, along with compositions and complexes thereof, optionally in combination with compounds of formula (Ib). Pharmaceutical formulations and methods of making and using such compounds are also disclosed.

Abstract: The present invention provides dry blend pharmaceutical formulations in unit dosage forms comprising per dosage unit one or more active pharmaceutical ingredients or pharmaceutically acceptable salts, solvates, hydrates, or combinations thereof wherein the ratio of said one or more active pharmaceutical ingredients in said formulations is essentially the same as the ratio of said active pharmaceutical ingredients in the corresponding, non-formulated drug substance and, wherein said formulations in unit dosage form are adapted for oral administration.